Can a cancer drug help MS patients think and move better?
NCT ID NCT06599307
Summary
This study is testing whether the drug rituximab can improve thinking skills and hand function in people with advanced secondary progressive multiple sclerosis (SPMS). Researchers will compare 46 participants with significant disability—half receiving rituximab and half receiving a placebo—over one year. The goal is to see if this treatment can help maintain or improve cognitive abilities, hand coordination, and overall quality of life for those living with progressive MS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kasr Alainy Multiple Sclerosis Unit (KAMSU), Cairo University hospitals.
RECRUITINGGiza, Giza Governorate, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.